November 17, 2009 (Orlando, Florida) — A 150-mg/day dosage of the angiotensin-receptor blocker (ARB) losartan (Cozaar, Merck) significantly cut the risk of death or heart-failure hospitalization over ...
In the largest comparison of angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors to date, a study of nearly 2.3 million patients starting the drugs as monotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results